Perkins Capital Management Inc has filed its 13F form on May 09, 2024 for Q1 2024 where it was disclosed a total value porftolio of $116 Million distributed in 90 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $9.83M, Microsoft Corp with a value of $6.36M, Augmedix, Inc. with a value of $5.96M, Idexx Laboratories Inc with a value of $5.67M, and Natera, Inc. with a value of $5.5M.

Examining the 13F form we can see an decrease of $1.23M in the current position value, from $117M to 116M.

Below you can find more details about Perkins Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $116 Million
Healthcare: $64.9 Million
Technology: $32.2 Million
Communication Services: $6.49 Million
Consumer Defensive: $5.18 Million
Industrials: $3.25 Million
Energy: $3.16 Million
Financial Services: $669,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 90
  • Current Value $116 Million
  • Prior Value $117 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 09, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 4 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.